🫁 Aspergillus in lung disease deserves more attention! A new study links it to worse outcomes in bronchiectasis patients. 🌟 Let’s raise awareness and advance diagnostics for fungal infections.
@MFT_NAC@MycologyRefManc @BTSrespiratory
📖 Read more: https://t.co/A4kYYx5TLz
@nifuscab and @MMSNIG working together have been instrumental to getting fungal diseases into Nigeria's public health agenda. Special kudos to @RitaOladele1 and members of her team @PetersFolake for their roles in setting up 🇳🇬 mycology reference lab
This year, we are concentrating on the need for medical mycology to be interfaced with public health to gain traction in awareness, diagnostics, drugs and research funding.
Register https://t.co/NhPhHPkSV4 and send in your abstracts.
Early bird ends July 31st
Cryptococcus accounts for up to 180,000 deaths annually and 68% of HIV-related meningitis cases. 🆕️🔥🌟 Review discussed diagnostic, preventive, and therapeutic strategies and the pathophysiological role of inflammatory syndromes. #IDXposts
https://t.co/tDXpw7QClm
The paediatric age group is neglected in the already neglected field of medical mycology. Concerted efforts are needed to generate data for public health action.
Our new funding model means that more LMIC researchers will be able to access NIHR funding.
We're also making it easier than ever for researchers to find appropriate funding opportunities with a clear, regular and predictable frequency of calls.
Read our news story:
The rapid emergence of antifungal-resistant human-pathogenic fungi
Lockhart & co. discuss the global emergence & spread of Candida auris, azole-resistant Aspergillus fumigatus & Trichophyton indotineae, all three emerging with a high rate of acquired resistance.
If you have chronic pulmonary aspergillosis, you can help with research on the quality of life of people living with this disease. All you need to do is fill out the questionnaire below! @MFT_NAC@CPA_HRQoL#CPA#research
📢 Can you help us by completing our survey?
Your input is incredibly important and will help us to develop a deeper understanding of how chronic pulmonary aspergillosis (CPA) is diagnosed and treated in the UK.
Please share.
#idtwitter#medtwitter
https://t.co/U0PNvdoNaE
The @WHO is inviting microbiologists, infectious diseases clinicians, and laboratory health systems experts to contribute to the development of a crucial "Model List of Essential Bacteriology and Mycology Diagnostic Tests 🍄🦠🙌
It is our time to act
https://t.co/XVSVBzNxoj